Review



mgmt promoter hypermethylation status  (INFINIUM Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    INFINIUM Inc mgmt promoter hypermethylation status
    Kaplan-Meier analysis of overall survival stratified by FGFR3 - TACC3 fusion ( a ) and <t>MGMT</t> promoter <t>hypermethylation</t> ( b ) status. Note : Overall survival was defined as the time from initial diagnostic biopsy until the time of death due to any cause. Two-sided p values for difference were calculated using the log-rank test
    Mgmt Promoter Hypermethylation Status, supplied by INFINIUM Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mgmt+promoter+hypermethylation+status/pmc07653727-53-1-27?v=INFINIUM+Inc
    Average 90 stars, based on 1 article reviews
    mgmt promoter hypermethylation status - by Bioz Stars, 2026-08
    90/100 stars

    Images

    1) Product Images from "Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3 - TACC3 fusions"

    Article Title: Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3 - TACC3 fusions

    Journal: Acta Neuropathologica Communications

    doi: 10.1186/s40478-020-01058-6

    Kaplan-Meier analysis of overall survival stratified by FGFR3 - TACC3 fusion ( a ) and MGMT promoter hypermethylation ( b ) status. Note : Overall survival was defined as the time from initial diagnostic biopsy until the time of death due to any cause. Two-sided p values for difference were calculated using the log-rank test
    Figure Legend Snippet: Kaplan-Meier analysis of overall survival stratified by FGFR3 - TACC3 fusion ( a ) and MGMT promoter hypermethylation ( b ) status. Note : Overall survival was defined as the time from initial diagnostic biopsy until the time of death due to any cause. Two-sided p values for difference were calculated using the log-rank test

    Techniques Used: Diagnostic Assay



    Similar Products

    mgmt promoter hypermethylation status  (INFINIUM Inc)
    90
    INFINIUM Inc mgmt promoter hypermethylation status
    Kaplan-Meier analysis of overall survival stratified by FGFR3 - TACC3 fusion ( a ) and <t>MGMT</t> promoter <t>hypermethylation</t> ( b ) status. Note : Overall survival was defined as the time from initial diagnostic biopsy until the time of death due to any cause. Two-sided p values for difference were calculated using the log-rank test
    Mgmt Promoter Hypermethylation Status, supplied by INFINIUM Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/mgmt+promoter+hypermethylation+status/pmc07653727-53-1-27?v=INFINIUM+Inc
    Average 90 stars, based on 1 article reviews
    mgmt promoter hypermethylation status - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Kaplan-Meier analysis of overall survival stratified by FGFR3 - TACC3 fusion ( a ) and MGMT promoter hypermethylation ( b ) status. Note : Overall survival was defined as the time from initial diagnostic biopsy until the time of death due to any cause. Two-sided p values for difference were calculated using the log-rank test

    Journal: Acta Neuropathologica Communications

    Article Title: Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3 - TACC3 fusions

    doi: 10.1186/s40478-020-01058-6

    Figure Lengend Snippet: Kaplan-Meier analysis of overall survival stratified by FGFR3 - TACC3 fusion ( a ) and MGMT promoter hypermethylation ( b ) status. Note : Overall survival was defined as the time from initial diagnostic biopsy until the time of death due to any cause. Two-sided p values for difference were calculated using the log-rank test

    Article Snippet: Reported MGMT promoter hypermethylation status, typically determined by pyrosequencing, was extracted from the electronic medical record for those patients who did not undergo methylation analysis on the Infinium platform [ ].

    Techniques: Diagnostic Assay